Specifically, in patients with haptoglobin genotype-2 (Hp2-2), vitamin E has been shown to be associated with an approximately 35% reduction in cardiovascular diseases in both type 1 diabetes and type 2 diabetes [113, 114]. The gene discussed is HP; the disease is type 1 diabetes mellitus.